Sun Pharm Drug Patent Portfolio

Sun Pharm's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Indian Firms Introduce Affordable Alternatives to Well-Known Weight Loss Medications - Fine Day Radio

23 Mar, 2026

India is introducing affordable weight-loss medications, while Novo Nordisk is relying on its brand strength to maintain its leading position.

23 Mar, 2026

Summary: Indian pharmaceutical companies are introducing more affordable alternatives to Novo's Ozempic and Wegovy.

23 Mar, 2026

Indian pharmaceutical company introduces affordable generics of Ozempic following patent expiration - Arab News

22 Mar, 2026